Arkolith/Insider Trading/VCEL/Form 4

Hopper Jonathan Mark

Chief Medical OfficerVericel Corp (VCEL) · full profile →Form 4 · filed Jun 30, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$450K
Net Open-Market Flow
-$450K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 26, 2026Option exercise(M)5K$29.82$149K81K
Jun 26, 2026Sell(S)5K$45.00$225K76K
Jun 26, 2026Option exercise(M)5K$29.82$149K81K
Jun 26, 2026Sell(S)5K$45.00$225K76K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 26, 2026Option exercise(M)5K—$025K
Jun 26, 2026Option exercise(M)5K—$020K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-26-026930) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML